Home > Products > CD89 & malaria antigen > Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (scIgG)

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (scIgG)  (SCIGG-134)

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD89 and anti-malaria antigen IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Specifications
Targets
CD89 & malaria antigen
Type
Single chain IgGs
Species Reactivity
Human
Target 1
CD89
Host Animal 1
Mouse
Target 2
malaria antigen
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Malaria
Targets
Target 1
CD89
Gene ID
UniProt ID
Alternative Names
FcαRI; FCAR; Fc fragment of IgA, receptor for; CD89; FcalphaRI; immunoglobulin alpha Fc receptor; Fc alpha receptor
Target 2
malaria antigen
Alternative Names
malaria antigen; parasitic protozoans
Our services and products are only for lab research, not for any diagnostic or therapeutic use.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Online Inquiry
USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Germany
Heidenkampsweg 58, 20097 Hamburg, Germany
Email:

UK
167-169 Great Portland Street, 5th Floor, London, W1W 5PE
Tel: 44-207-097-1828
Email:
Related products of "CD89 & malaria antigen"
24x7 CUSTOMER SERVICE
Easy access to products and services you need from our library via
powerful searching tools
© 2021 Creative-Biolabs All Rights Reserved.
Distributors
To view the contact information for a specific location,
select your country or region: